Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy

Haim Werner*, Rive Sarfstein, Ilan Bruchim

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Investigational IGF1R inhibitors in early stage clinical trials for cancer therapy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science